solution for infusion 5 mg/ml 100 ml
Trade name: Metronidazole, solution for infusion 5 mg/ml 100 ml.
International non- proprietary name: Metronidazole.
Description: clear colorless or white a pale greenish- yellow tint liquid.
Composition: 1 ml of the solution contains:
Active substance: metronidazole – 5 mg.
Adjuvant components: sodium chloride and water for injection.
Pharmacotherapeutic group: Synthetic antibacterial agents. Imidazole derivatives.
ATC code: J01XD01.
Indications for use:
► Protozoal infections
Extraintestinal amebiasis, amebic liver abscess included, intestinal amebiasis (amebic dysentery), trichomoniasis, balantidiasis, lambliasis (giardiasis), dermal leishmaniasis, trichomonal vaginitis and trichomonal urethritis.
Infections caused by Bacteroides spp. (including Bacteroides fragilis, Bacteroides distasonis, Bacteroides ovatus, Bacteroides thetaiotaomicro and Bacteroides vulgatus): bone and joint infections, central nervous system infections, including meningitis, cerebral abscess, bacterial endocarditis, pneumonia, pulmonary empyema and abscess and sepsis.
► Infections caused by species Clostridium spp., Peptococcus and Peptostreptococcus: abdominal cavity infections (peritonitis and hepatic abscess) and pelvis minor organ infections (endometritis, Fallopian tube and ovary abscess and vaginal vault infections).
► Pseudomembranous colitis (antibiotics administration related). Gastritis or duodenal ulcer related to Helicobacter pylori.
► Post-surgery complication prevention (particularly operative interventions in colon and pararectal area, appendectomy and gynecological surgeries).
► Radiotherapy of tumor patients – as a radiation sensitizing medicinal agent in cases the tumor resistance is due to the tumor cell hypoxia.